多组学孟德尔随机化联合微阵列、单细胞与空间RNA测序识别白癜风潜在治疗靶点
研究整合多组学孟德尔随机化、微阵列、单细胞及空间RNA测序,从4479个可成药基因中筛选白癜风治疗靶点,发现CTSS治疗潜力最高。临床样本与生信分析显示CTSS在白癜风皮损黑素细胞及晕痣中上调,与抗原提呈细胞和CD8+ T细胞浸润及免疫原性细胞死亡相关。体外实验证实氧化应激通过IRF1促进CTSS表达,释放损伤相关分子模式,抑制CTSS可能成为白癜风治疗新策略。
要点
- CTSS被多组学孟德尔随机化筛选为白癜风治疗潜力最高的靶点。
- CTSS在白癜风皮损黑素细胞和晕痣中表达上调。
- 氧化应激通过IRF1上调CTSS,促进抗原提呈与免疫原性细胞死亡。
核心结论
- 氧化应激通过IRF1介导的CTSS上调可能驱动自身抗原暴露、损伤相关分子模式释放、抗原提呈增强及抗原提呈细胞活化,从而触发自身免疫反应和免疫原性细胞死亡,参与白癜风发病。
- 抑制CTSS可能为白癜风提供潜在治疗途径。
研究设计与样本
- 研究采用多组学孟德尔随机化分析,使用4479个可成药基因的定量性状位点数据,结合GWAS Catalog和FinnGen consortium的白癜风GWAS数据。
- 对候选靶点进行综合验证,包括临床样本分析、生物信息学分析、单细胞RNA测序、空间RNA测序及体外实验。
主要发现
- 在候选基因中,CTSS经综合验证后显示最高治疗潜力。
- 临床样本和生物信息学分析显示CTSS在白癜风皮损黑素细胞和晕痣中上调。
- 单细胞和空间转录组测序表明CTSS表达升高与抗原提呈细胞和CD8+ T细胞浸润增加相关,并与免疫原性细胞死亡强相关。
- 体外实验证实氧化应激通过IRF1促进CTSS表达,导致损伤相关分子模式释放。
临床怎么用
- CTSS可作为白癜风潜在治疗靶点,抑制CTSS可能为白癜风治疗提供新方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vitiligo is a chronic skin disorder characterized by the selective destruction of melanocytes. Current treatments, such as topical steroids, tacrolimus, systemic steroids, and phototherapy, often yield suboptimal efficacy, underscoring the urgent need for more effective therapeutic targets. To identify potential drug targets, we conducted multiomics Mendelian randomization analyses using quantitative trait loci data for 4479 druggable genes in combination with vitiligo GWAS data from the GWAS Catalog and the FinnGen consortium. Among these candidates, CTSS demonstrated the highest therapeutic potential after comprehensive validation. Clinical samples and bioinformatics analyses revealed that CTSS was upregulated in melanocytes from vitiligo lesions and halo nevi. Single-cell and spatial transcriptomic sequencing further indicated that elevated CTSS expression was associated with increased infiltration of antigen-presenting cells and CD8+ T cells and strongly correlated with immunogenic cell death. In vitro experiments confirmed that oxidative stress promotes CTSS expression through IRF1, leading to the release of damage-associated molecular patterns. In conclusion, oxidative stress-mediated CTSS upregulation through IRF1 may drive autoantigen exposure, damage-associated molecular pattern release, enhanced antigen presentation, and antigen-presenting cell activation, thereby triggering autoimmune responses and immunogenic cell death, ultimately contributing to vitiligo pathogenesis. Inhibiting CTSS could offer a potential therapeutic approach for vitiligo.
引用
- Huang J, Hu Y, Zhang Y, et al. Integrating Multiomic Mendelian Randomization, Microarray, Single-Cell RNA Sequencing, and Spatial RNA Sequencing to Identify Potential Therapeutic Targets for Vitiligo. J Invest Dermatol. 2025. PMID: 41005615. doi:10.1016/j.jid.2025.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。